During the last session, Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares were 0.73 million, with the beta value of the company hitting 1.42. At the end of the trading day, the stock’s price was $3.31, reflecting an intraday loss of -4.34% or -$0.15. The 52-week high for the CKPT share is $4.50, that puts it down -35.95 from that peak though still a striking 58.31% gain since the share price plummeted to a 52-week low of $1.38. The company’s market capitalization is $161.64M, and the average intraday trading volume over the past 10 days was 0.93 million shares, and the average trade volume was 1.37 million shares over the past three months.
Checkpoint Therapeutics Inc (CKPT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CKPT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information
Checkpoint Therapeutics Inc (CKPT) registered a -4.34% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.34% in intraday trading to $3.31, hitting a weekly high. The stock’s 5-day price performance is 0.61%, and it has moved by -0.60% in 30 days. Based on these gigs, the overall price performance for the year is 74.21%. The short interest in Checkpoint Therapeutics Inc (NASDAQ:CKPT) is 7.76 million shares and it means that shorts have 9.03 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.32%. While earnings are projected to return 72.34% in 2025.
CKPT Dividends
Checkpoint Therapeutics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s Major holders
Checkpoint Therapeutics Inc insiders own 30.04% of total outstanding shares while institutional holders control 18.50%, with the float percentage being 26.44%.
Also, the Mutual Funds coming in first place with the largest holdings of Checkpoint Therapeutics Inc (CKPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.09 shares. This amounts to just over 2.27 percent of the company’s overall shares, with a $3.62 million market value. The same data shows that the other fund manager holds slightly less at 265.74, or about 0.55% of the stock, which is worth about $0.88 million.
